Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer
Anticancer Research · 2024
DOI: 10.21873/anticanres.16985 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Fabian Huber und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Medical Center-University of Freiburg, Freiburg, Germany. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, ErbB Receptors, Erb-b2 Receptor Tyrosine Kinases, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Medical Center-University of Freiburg, Freiburg, Germany.
- Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Faculty of Biology, University of Freiburg, Freiburg, Germany.
- Institute for Organic Chemistry, University of Freiburg, Freiburg, Germany.
- Core Facility Signalling Factory & Robotics, University of Freiburg, Freiburg, Germany.
- BIOSS Centre for Biological Signalling Studies, University of Freiburg, Freiburg, Germany.
Zitieren
APA
Huber, F., Wolf, I., Storz, J., Schultze-Seemann, S., Lauw, S., Klemenz, L., Miernik, A., Gratzke, C., Brückner, R., & Wolf, P. (2024). Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16985
Vancouver
Huber F, Wolf I, Storz J, Schultze-Seemann S, Lauw S, Klemenz L, et al. Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.16985
BibTeX
@article{Huber2024,
author = {Huber, Fabian and Wolf, Isis and Storz, Jonas and Schultze-Seemann, Susanne and Lauw, Susan and Klemenz, Lukas and Miernik, Arkadiusz and Gratzke, Christian and Brückner, Reinhard and Wolf, Philipp},
title = {Antibody-dye Conjugates Targeting EGFR and HER2 for the Photoimmunotherapy of Bladder Cancer},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.16985}
}
EUVIMED